Although the role of Hh-related autophagy seems to be confused currently, encouraging results from MYCN-amplified neuroblastoma and BCR-ABL mutation CML studies underscored the possibility of co-modulating Hh signaling and autophagy to overcome drug resistance in different cancer domains. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.